Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency Overview
Learn About Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency
Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is an inherited disorder that impairs the body's ability to break down ketones, which are molecules produced in the liver during the breakdown of fats.
Mutations in the OXCT1 gene cause SCOT deficiency. The OXCT1 gene provides instructions for making an enzyme called succinyl-CoA:3-ketoacid CoA transferase (SCOT). The SCOT enzyme is made in the energy-producing centers of cells (mitochondria). The enzyme plays a role in the breakdown of ketones, which are an important source of energy during fasting or when energy demands are increased, such as during illness or when exercising.
The prevalence of SCOT deficiency is unknown. More than 20 cases of this condition have been reported in the scientific literature.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Toshiyuki Fukao-Shigemura practices in Gifu-shi, Japan. Fukao-Shigemura is rated as an Elite expert by MediFind in the treatment of Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency. Their top areas of expertise are Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency, Beta-Ketothiolase Deficiency, Metabolic Acidosis, and Primary Carnitine Deficiency.
University Hospitals Medical Group Inc
James Strainic is a Pediatric Cardiologist and a Pediatrics provider in Cleveland, Ohio. Dr. Strainic is rated as an Experienced provider by MediFind in the treatment of Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency. His top areas of expertise are Pulmonary Atresia, Pulmonary Atresia with Intact Ventricular Septum, Ventricular Septal Defects, and Congenital Coronary Artery Malformation. Dr. Strainic is currently accepting new patients.
Jorn Sass practices in Rheinbach, Germany. Mr. Sass is rated as a Distinguished expert by MediFind in the treatment of Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency. His top areas of expertise are Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Beta-Ketothiolase Deficiency, and Molybdenum Cofactor Deficiency (MoCD).
Published Date: December 01, 2011
Published By: National Institutes of Health